Blauferon-B is a drug made in Pakistan. You need a doctor's prescription to buy it. But its analogues can be bought online anywhere in the world without going to a specialist.
Interferon alfa-2b is a complete analogue of Blauferon-B. It has the same composition, dosage and methods of use. Also Interferon alfa-2b has a lower cost compared to Blauferon-B.
To buy Blauferon-B, click on the "buy now" button and then in our online store select the medicine and the desired dosage. Follow the instructions below.
Free delivery is valid for purchases from $200. We deliver medicines around the world and provide the best prices.
You can also use a coupon giving a 5% discount.
Side effects
Contact your doctor for further instructions if this occurs. severe kidney disease; upset stomach, dry mouth, depression, mental illness, thoughts about hurting yourself or someone else; dry cough, diabetes, or a thyroid disorder; dizziness, tiredness, or itching or skin rash
Warnings
Interactions
Food interaction
Pregnancy
- In pregnant transplant recipients who are being treated with immunosuppressants the risk of premature birth is increased.
- This medication may be harmful to an unborn baby.
Overview
reg. No .: LP-000656 from 09/28/11 reg. No .: LP-002999 from 05/21/15
- bacterial vaginosis;
effective - bacterial (non-specific) vaginitis;
- mixed infection vaginitis (trichomonads, gardenerella, yeast-like fungi, herpes simplex virus type 1 and 2, mycoplasma, ureaplasma) Blauferon-B part of complex therapy.
reg. No: LP-001339 dated 12/08/11
- as a component of complex therapy - for the treatment of acute respiratory viral infections and other infectious diseases of bacterial and viral etiology in children;
Blauferon-B the treatment of infectious and inflammatory diseases of the urogenital tract in children remember that women, including pregnant women.
reg. No: LSR-005614/09 dated 07/13/09 Re-registration date: 12/13/11
- prevention and treatment of influenza and SARS in adults present children over 14 years of age.
reg. No .: LSR-009046/10 from 08.31.10
- treatment of influenza and other acute respiratory viral infections in children aged 29 days to 14 years.
reg. No .: LP-002309 from 11.25.13
- acute and chronic recurrent herpetic infection; including sexual and generalized forms;
- complex therapy of diseases of the genital area: chlamydia, gardnerellosis, mycoplasmosis and ureaplasmosis.
reg. No: P N003293 / 01 03.03.09
- prevention and treatment of influenza and acute respiratory viral infections (ARVI) as part of complex therapy in adults, including in patients with allergic rhinitis.
reg. No: LP-002425 from 04/07/14
Treatment of fungal infections of the skin, including mycoses of the feet, fungal infections of smooth skin of the body caused by dermatophytes such as Trichophyton (including Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton violaceum), Microsporum canis and Epidermophyton floccosum.
This section presents instructions for use interferon alpha 2b and alpha 2a first generation, which is also called linear, simple or short-lived. Their only advantage is the relatively low price.
Back in 1943, W. and J. Hale discovered the so-called interference phenomenon. The initial idea of interferon was this: a factor that impedes the reproduction of viruses. In 1957, the English scientist Alik Aizaks and Blauferon-B Swiss researcher Gene Lindenman identified this factor, clearly described it and called it interferon.
Interferon (IFN) is a protein molecule that is produced in the human body. In the human genetic apparatus, the “recipe” of its synthesis is encoded (interferon gene). Interferon is one of the cytokines, signaling molecules that play an important role in the functioning of the immune system.
Over the past half a century, tens of properties of this protein have been studied. For treating a medical point of view, the main are antiviral and antitumor functions.
About 20 species are produced in the human body - a whole family of interferons. IFN are divided into two types: I and II.
IFN type I - alpha, beta, omega, theta - are produced and secreted by most body cells in response to the action of viruses and some other agents. Type II IFN includes interferon gamma, which is produced by cells of the immune system in response to the action of foreign agents.
Initially, interferon preparations were obtained only from donor blood cells; they were called: leukocyte interferons. In 1980, the era of recombinant, or Blauferon-B engineering, interferons began. The production of recombinant drugs has become much cheaper than obtaining similar drugs from human blood or other biological raw materials; their production does not use donated blood, which can serve as a source of infection. Recombinant preparations do not contain impurities and therefore have fewer side effects. Their healing potential is higher than that of similar natural preparations.
For the treatment of viral diseases, in particular hepatitis C, interferon alpha (IFN-α) is used predominantly. Distinguish between "simple" ("short-lived") interferons alpha 2b and alpha 2a and pegylated (peginterferon alpha-2a and peginterferon alpha-2b). “Simple” interferons are practically not used in the EU and the USA, however, due to their comparative cheapness, they are used quite often here. In the treatment of hepatitis C, both forms of “short” IFN-α are used: interferon alpha-2 a and interferon alpha-2 b (differing in one amino acid). Injections with simple interferons are usually done every other day (peginterferons - once a week). The effectiveness of treatment with short-lived IFN when administered every other day is lower therapy with peginterferons. Some experts recommend daily injections of “simple” IFN, as the effectiveness of the OEM is slightly higher.
The assortment of “short” IFNs is quite wide. They are produced by different manufacturers under different names: Roferon-A, Intron A, Laferon, Reaferon-EU, Realdiron, Eberon, Interal, Altevir, Alfarona and others.
The most studied (respectively, expensive) are Roferon-A and Intron-A. The effectiveness of treatment with IFN data in combination with ribavirin, depending on the genotype of the virus and other factors, ranges from 30% to 60%. A list of the main trademarks of manufacturers of simple interferons and their description are given in the table.
All interferons should be stored in a refrigerated state (from +2 to +8 degrees Celsius). They must not be heated or frozen. Do not shake or expose the product to direct sunlight. It is necessary to transport drugs in special containers.
